Angiotensin-converting enzyme gene polymorphisms and prognosis in chronic thromboembolic pulmonary hypertension

Circulation Journal

Volumn 70, Issue 9, 2006, Pages 1174-1179

  Tanabe, Nobuhiro ^a   Amano, Shinya ^a   Tatsumi, Koichiro ^a   Kominami, Satoshi ^a   Igarashi, Natsuhiko ^a   Shimura, Ryuhi ^a   Matsubara, Hiroshi ^a   Kasahara, Yasunori ^a   Takiguchi, Yuichi ^a   Kuriyama, Takayuki ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Angiotensin converting enzyme; Genetics; Pulmonary embolism; Pulmonary hypertension

Indexed keywords

BERAPROST; DIPEPTIDYL CARBOXYPEPTIDASE; DIURETIC AGENT; WARFARIN;

ADULT; AGED; ALLELE; ARTICLE; BLOOD FILTER; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; ENDARTERECTOMY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN THERAPY; PROGNOSIS; PULMONARY HYPERTENSION; THROMBOEMBOLISM; VASCULAR RESISTANCE;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHRONIC DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMBOLISM; RISK FACTORS;

EID: 33748650330     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.1174     Document Type: Article

References (38)

1. Moser KM, Auger WR, Fedullo PF. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation 1990; 81: 1735-1743.
2. Fedullo PF, Auger WR, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001; 345: 1465-1472.
3. Tanabe N, Okada O, Nakagawa Y, Masuda M, Kato K, Nakajima N, et al. The efficacy of pulmonary thromboendarterectomy on long-term gas exchange. Eur Respir J 1997; 10: 2066-2072.
4. Pengo V, Lensing AWA, Prins MH, Marchiori A, Davidson BL, Tiozzo F, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004; 350: 2257-2264.
5. Sugimura K, Sakuma M, Shirato K. Potential risk factors and incidence of pulmonary thromboembolism in Japan: Results from an overview of mailed questionnaires and matched case-control study. Circ J 2006; 70: 542-547.
6. Riedel M, Stanek V, Widimsky J, Prerovsky I. Longterm follow-up of patients with pulmonary thromboembolism: Late prognosis and evolution of hemodynamic and respiratory data. Chest 1982; 81: 151-158.
7. Busjahn A, Knoblauch H, Knoblauch M, Bohlender J, Menz M, Faulhaber HD, et al. Angiotensin-converting enzyme and angiotensinogen gene polymorphisms, plasma levels, cardiac dimensions: A twin study. Hypertension 1997; 29: 165-170.
8. Cambien F, Poirier O, Lecerf L, Evans A, Cambou J-P, Arveiler D, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme gene is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-644.
9. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, et al. Angiotensin-converting enzyme DD genotype in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet 1993; 342: 1073-1075.
10. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994; 90: 2199-2202.
11. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 330: 1634-1638.
12. Takahashi N, Smithies O. Human genetics, animal models and computer simulations for studying hypertension. Trends Genet 2004; 20: 136-145.
13. Phillip CS, Dilley A, Saidi P, Evatt B, Austin H, Zawadsky J, et al. Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty. Thromb Haemost 1998; 80: 869-873.
14. Fatini C, Gensini F, Sticchi E, Battaglini B, Prisco D, Fedi S, et al. ACE DD genotype: An independent predisposition factor to venous thromboembolism. Eur J Clin Invest 2003; 33: 642-647.
15. Dzau VJ. Vascular renin-angiotensin system and vascular protection. J Cardiovasc Pharmacol 1990; 15: S6-S139.
16. Mulder HJGH, van Geel PP, Schalij MJ, van Gilst WH, Zwinderman AH, Bruschke AVG. DD ACE gene polymorphism is associated with increased coronary artery endothelial dysfunction: PREFACE trial. Heart 2003; 89: 557-558.
17. Kanazawa H, Okamoto Y, Hirata K, Yoshikawa J. Deletion polymorphisms in the angiotensin converting enzyme gene are associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162: 1235-1238.
18. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxy peptidase 1). Nucl Acids Res 1992; 20: 1433.
19. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
20. Orte C, Polak JM, Haworth SG, Yacoub MH, Morrell NW. Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension. J Pathol 2000; 192: 379-384.
21. Okada K, Bernstein ML, Zhang W, Yacoub MH, Morrell NW. Angiotensin-converting enzyme inhibition delays pulmonary vascular neointimal formation. Am J Respir Crit Care Med 1998; 158: 939-950.
22. Daily PO, Dembitsky WP, Peterson KL, Moser KM. Modifications of techniques and early results of pulmonary thromboendarterectomy for chronic pulmonary embolism. J Thorac Cardiovasc Surg 1987; 93: 221-233.
23. Sakuma M, Nakamura M, Nakanishi N, Miyahara Y, Tanabe N, Yamada N, et al. Clinical characteristics, diagnosis and management of patients with pulmonary thromboembolism who are not diagnosed in the acute phase and not classified as chronic thromboembolic pulmonary hypertension. Circ J 2005; 69: 1009-1015.
24. Auger WR, Fedullo PF, Moser KM, Buchbinder M, Peterson KL. Chronic major-vessel thromboembolic pulmonary artery obstruction: Appearance at angiography. Radiology 1992; 182: 393-398.
25. Ueda S, Heely RP, Lees KR. Mistyping of the human angiotensin-converting enzyme gene polymorphism: Frequency, causes and possible methods to avoid errors in typing. J Mol Endocrinol 1996; 17: 27-30.
26. Ono F, Nagaya N, Okumura H, Shimizu Y, Kyotani S, Nakanishi N, et al. Effect of orally active prostacyclin analogue on survival in patients with chronic thromboembolic pulmonary hypertension without major vessel obstruction. Chest 2003; 123: 1583-1588.
27. Abraham WT, Raynolds MV, Badesch DB, Wynne KM, Groves BM, Roden RL, et al. Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: Increased frequency and association with preserved haemodymamics. J Renin Angiotensin Aldosterone Syst 2003; 4: 27-30.
28. van Suylen R J, Wouters EF, Pennings HJ, Cheriex EC, van Pol PE, Ambergen AW, et al. The DD genotype of the angiotensin converting enzyme gene is negatively associated with right ventricular hypertrophy in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 1791-1795.
29. Higaki J, Baba S, Katsuya T, Sato N, Ishikawa K, Mannami T, et al. Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men: The Suita Study. Circulation 2000; 101: 2060-2065.
30. O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, et al. Evidence for association and genetic linkage of the angiotensin- converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart. Circulation 1998; 97: 1766-1772.
31. Takahashi N, Hagaman JR, Kim HS, Smithies O. Minireview: Computer simulations of blood pressure regulation by the renin-angiotensin system. Endocrinology 2003; 144: 2184-2190.
32. Miyamoto S, Nagaya N, Satoh T, Kyotani S, Sakamaki F, Fujita M, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension: Comparison with cardio-pulmonary exercise testing. Am J Respir Crit Care Med 2000; 161: 487-492.
33. Tamaki S, Nakamura Y, Tsujita T, Nozaki A, Amamoto K, Kadowaki T, et al. Polymorphism of the Angiotensin converting enzyme gene and blood pressure in a Japanese general population (the Shigaraki Study). Hypertens Res 2002; 25: 843-848.
34. Zaman MM, Yoshiike N, Date C, Yokoyama T, Matsumura Y, Ikemoto S, et al. Angiotensin converting enzyme genetic polymorphism is not associated with hypertension in a cross-sectional sample of a Japanese population: The Shibata Study. J Hypertens 2001; 19: 47-53.
35. Thomson JR, Machado RD, Pauciulo MW, Morgan NV, Humbert M, Elliott GC, et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J Med Genet 2000; 37: 741-745.
36. Sugiyama S, Hirota H, Yoshida M, Takemura Y, Nakaoka Y, Oshima Y, et al. Novel insertional mutation in the bone morphogenetic protein receptor type II associated with sporadic primary pulmonary hypertension. Circ J 2004; 68: 592-594.
37. Tanabe N, Kimura A, Amano S, Okada O, Kasahara Y, Tatsumi K, et al. Association of clinical features with HLA in chronic pulmonary thromboembolism in Japan. Eur Respir J 2005; 25: 131-138.
38. Thistlethwaite PA, Mo M, Madani MM, Deutsch R, Blanchard D, Kapelanski DP, et al. Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. J Thoracic Cardiovasc Surg 2002; 124: 1203-1211.